Anaplastic thyroid carcinoma transformation in a lateral neck node metastasis - A case report and a review of the literature by Gunnarsdottir, Agnes B et al.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=icro20
Acta Oto-Laryngologica Case Reports
ISSN: (Print) 2377-2484 (Online) Journal homepage: https://www.tandfonline.com/loi/icro20
Anaplastic thyroid carcinoma transformation in a
lateral neck node metastasis – A case report and a
review of the literature
Agnes B. Gunnarsdottir, Birgir A. Briem, Larus Jonasson & Geir Tryggvason
To cite this article: Agnes B. Gunnarsdottir, Birgir A. Briem, Larus Jonasson & Geir Tryggvason
(2018) Anaplastic thyroid carcinoma transformation in a lateral neck node metastasis – A case
report and a review of the literature, Acta Oto-Laryngologica Case Reports, 3:1, 43-46, DOI:
10.1080/23772484.2018.1506256
To link to this article:  https://doi.org/10.1080/23772484.2018.1506256
© 2018 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group.
Published online: 08 Sep 2018.




Anaplastic thyroid carcinoma transformation in a lateral neck node
metastasis – A case report and a review of the literature
Agnes B. Gunnarsdottira, Birgir A. Briemb, Larus Jonassonc and Geir Tryggvasonb
aDepartment of Otolaryngology and Head and Neck Cancer, Skanes Universitetssjukhus Lund, Lund, Sweden; bDepartment of
Otolaryngology – Head and Neck Surgery, Landspitali University Hospital, Reykjavik, Iceland; cDepartment of Surgical Pathology,
Landspitali University Hospital, Reykjavik, Iceland
ABSTRACT
Anaplastic thyroid carcinoma is thought to be derived from previous existing papillary or
follicular thyroid carcinoma that dedifferentiates into its anaplastic counterpart. We present a
case where this type of dedifferentiation occurs at a metastatic site in a regional lymph node,
years after the primary papillary thyroid tumor had metastasized.
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Papillary thyroid carcinoma (PTC) is the most common
malignancy of the thyroid and accounts for up to 80%
of all thyroid carcinomas. It carries an excellent progno-
sis, with 10-year survival of over 90% [1]. Anaplastic
thyroid carcinomas are much rarer, representing
approximately 2% of all thyroid cancers. These, how-
ever, are aggressive in behavior and carry a very poor
prognosis, with mean survival of six months after diag-
nosis. Anaplastic thyroid carcinomas are responsible for
almost half of thyroid cancer-related deaths [2].
It has been widely accepted that anaplastic thyroid
carcinomas arise from a previous existing papillary
(PTC) or follicular carcinoma of the thyroid, with
PTC being the most common pre-transformational
subtype [3]. It is much rarer that anaplastic trans-
formation occurs at a metastatic site, whether this
being a metastatic lymph node or distant metastatic
site. We present a case where an anaplastic carcinoma
developed in a lateral neck node metastasis without
transformation of the primary.
Clinical summary
A 79-year-old male presented to his primary phys-
ician because of intermittent fevers for a few months
without any other symptoms. His prior medical his-
tory was remarkable for prostate cancer, depression
and repeated lower respiratory tract infections and
urinary tract infections.
During the workup he developed a rapidly growing
tumor on the right side of his neck which had devel-
oped over just a few days. A CT scan of the neck and
chest was obtained urgently. It showed a large tumor
(6 7 4 cm) in the lateral neck compartment, fairly
well circumscribed but with central necrosis (Figure 1).
A calcified nodule in the right thyroid lobe was discov-
ered as well. When reviewing CT scans of the patient
from three years prior it appeared as if this tumor was
also present then, but much smaller in size (Figure 2).
At that time, it was described as an enlarged lymph
node, but no further workup was performed. There
were no signs of distant metastases.
The patient was referred urgently to our department
for further workup. On ultrasound the tumor was
hypoechogenic with microcalcifications (Figure 3). Core
biopsies taken from the tumor showed findings most
consistent with a metastasis from an anaplastic thyroid
carcinoma. When discussing the diagnosis with the
patient a week later the tumor had gotten visibly larger.
He was scheduled for urgent surgery.
Two days later the patient was admitted for a right
hemithyroidectomy and a radical right neck dissection.
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At surgery the tumor in the neck was fairly well cir-
cumscribed, but with visible invasion of the prevertebral
musculature. The right lobe of the thyroid gland was
removed as well.
The pathologic examination showed a large metas-
tasis with mixed PTC and anaplastic thyroid carcin-
oma (Figure 4) as well as metastases of PTC in 2
of 25 lymph nodes. In the right lobe of the thyroid
Figure 1. CT scan of the neck showing a well circumscribed large tumor (6 74 cm) in the lateral neck compartment with
central necrosis.
Figure 2. CT scan of the neck three years prior; a tumor present at the same site, then described as an enlarged lymph node.
Figure 3. Ultrasound image of the tumor showing the hypoechogenic mass with multiple microcalcifications.
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there was multifocal PTC but no focus of anaplas-
tic carcinoma.
Postoperatively the patient did well. He was dis-
charged on the fourth postoperative day and was
referred to the radiation oncology department for
postoperative radiation therapy. He started radiation
therapy 3 weeks after surgery and received 66Gy to
the neck. Three months after he finished the radiation
he developed aspiration pneumonia and died of
sepsis. There was evidence of metastases in the lungs
and carcinomatosis in the abdomen on CT scans.
An autopsy was not performed.
Discussion
Prognosis of primary anaplastic carcinoma of the thy-
roid is poor. However, the prognosis of patients with
a PTC primary but a dedifferentiated anaplastic
carcinoma metastasis is less known. A few case
reports have been published, but no statistic mortality
rate can be deduced from these case reports.
Ito et al. presented five cases of PTC showing ana-
plastic transformation in regional lymph nodes that
were curatively resected. Of these 5 patients two died
from the malignancy, two patients survived up to the
publication of the article (6 and 85 months after
resection) and one patient died from other causes [4].
Presentation of these type of malignancies, i.e.
dedifferentiation of metastatic PTC in lymph nodes, is
often that the patient notices a rapidly enlarging
cervical mass [5,6]. If distant metastasis is already
present at the time of diagnosis the presentation can
vary; the patient can present with systemic symptoms
of lethargy, anemia, tiredness, etc. [7], or the patient
can present with local pain in the area of metastasis [8].
In the case presented by Benedict and Costa the
diagnosis of metastatic anaplastic transformation of a
primary PTC was made incidentally [9].
There are reports of anaplastic transformations of
PTC tumors at distant metastatic sites. Both Al-Qsous
and Miller and Abe et al. reported, in two separate case
reports, anaplastic transformation in multiple lung meta-
stases from differentiated PTC [7,10]. In both cases the
patient had been treated for PTC a decade earlier. This
behavior, i.e. metastatic anaplastic transformations of
PTC many years after discovery of the thyroid primary
tumor, seems to be a common denominator in case
reports similar to ours. Sotome et al. reported a case of
anaplastic transformation of a metastatic PTC in the ret-
roperitoneum that presented 17 years after the primary
thyroid tumor was resected [8]. It is also of interest that
anaplastic transformation of PTC metastasis has been
reported to occur synchronously at several metastatic
sites, as reported by Benedict and Costa [9]. In our case
the anaplastic transformation of the PTC metastasis
probably occurred more than three years after the pri-
mary PTC tumor had metastasized, considering the CT
scan results from 2014 when a tumor at the exact same
site was described as an enlarged lymph node.
Treatment for metastatic anaplastic transformation
of PTC depends on the location but in our case con-
sisted of ipsilateral hemithyroidectomy with ipsilateral
modified radical neck dissection, followed by radio-
therapy. Ito et al. reported five separate cases in their
article, where all patients underwent curative resec-
tion, although postoperative radiotherapy was only
reported in three of the patients [4]. When distant
metastasis is present upon diagnosis the treatment is
radiation therapy, with or without surgical treatment,
but always with the addition of chemotherapy [11].
Figure 4. Metastatic PTC (on the right) with anaplastic transformation (on the left).
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Our case highlights the aggressive nature of ana-
plastic tumors, considering that in a matter of less
than two weeks an anaplastic dedifferentiated tumor
had grown from being unpalpable to a mass over 8cm
in diameter.
Conclusions
Anaplastic thyroid carcinoma is thought to arise by
progressive accumulation of genetic mutations in pre-
viously existing papillary or follicular thyroid carcin-
oma. Very rarely this transformation occurs at a
metastatic site, as in the case we are reporting. Not
much is known about prognosis for these patients
because of how rare these occurrences are.
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